FTC Under Trump Likely to Maintain PBM Focus But M&A Oversight May Moderate

 
• By Cathy Kelly
  
Attention is Turning To the Incoming Trump Administration. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Elections

More from Legislation